Tau PET in Imaging and Cognition: Healthy Adults From 55-90
Part of paid clinical trials in New York, New York.
- Sponsor
- Yaakov Stern
- Study ID
- NCT03372317
- Status
- Recruiting
Conditions
- Aging
- Mild Cognitive Impairment
Eligibility Criteria
- Sex
- ALL
- Age
- 55 Years - 90 Years
- Healthy Volunteers
- Accepted
Interventions
- 18F-MK-6240 — DRUGResults of the 18F-MK-6240 PET scan will be correlated with other observations.
Study Details
The investigators aim to use the new PET radioligand, 18F-MK-6240, to detect tau pathology in cognitive healthy and mild cognitive impairment (MCI) elders. The investigators will then examine the interactions between differential tau burden and performance on cognitive tasks, functional magnetic resonance imaging (fMRI) neural activation patterns, and other cognitive and behavioral measures. By investigating these relationships, the investigators hope to understand the cognitive and behavioral outcomes of tau deposition found in specific brain regions in cognitively normal/mildly cognitively impaired adults. Furthermore, the study aims to examine how the presence of tau may contribute to the risk of subsequent cognitive decline, neurodegeneration, and dementia.
Key Dates
- Start date
- Jun 1, 2018
- Status verified
- Feb 2026
- Primary completion
- Jan 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 105 participants (estimated)
Arms
- Arm: Non-demented eldersParticipants aged 55-90 that are cognitively normal or have mild cognitive impairment will receive 18F-MK-6240 to identify the presence of tau protein in the brain.
Primary Outcome Measure
Total number of individuals with tau present [ Time Frame: Up to 5 years ]
Central Contacts
- Reshma Babukutty212-305-6314
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Columbia University Medical Center | New York | New York | 10032 | Yaakov Stern, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in New York, NY
Related Studies
- Longitudinal Early-onset Alzheimer's Disease Study ProtocolRecruiting · Indiana University · Sun City, Arizona
- The Comparative Effectiveness Dementia & Alzheimer's RegistryEnrolling By Invitation · Weill Medical College of Cornell University · New York, New York
- Autoimmune Features of Neurodegenerative DisordersRecruiting · Columbia University · New York, New York
- Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverYRecruiting · Massachusetts General Hospital · Phoenix, Arizona